Tixylix Blackcurrant Cough Syrup 100 mL is a trusted, over-the-counter (OTC) cough remedy specifically formulated for young children aged 3 months to 5 years. Presented in a pleasant blackcurrant flavour that children readily accept, Tixylix provides gentle, effective symptomatic relief from dry, tickly, and irritating coughs associated with common colds and minor upper respiratory tract infections.
Tixylix is one of the most widely recognised paediatric cough syrups in the UK and across global pharmacy markets, with a long-standing reputation for safety and tolerability in young children. Its formulation is specifically designed for the youngest and most vulnerable paediatric age group — containing a gentle antitussive agent at age-appropriate doses without alcohol or harsh additives. If you are looking to buy Tixylix Blackcurrant Cough Syrup in Kenya, this product is available at registered pharmacies nationwide and is a trusted first-line choice for dry cough relief for children in Kenya. The price of Tixylix Cough Syrup in Kenya is accessible, making it a practical and reassuring option for parents managing their child’s cough symptoms.
Key Benefits
- Specifically formulated for young children aged 3 months to 5 years — not a diluted adult product
- Gentle antitussive action — soothes and suppresses dry, tickly, and irritating coughs without harsh sedating effects
- Pleasant blackcurrant flavour — improves compliance in young children who may resist taking medicine
- Alcohol-free formulation — appropriate and safe for young children
- Sugar-free or low-sugar formulation — gentle on developing teeth
- Fast-soothing action — provides symptomatic comfort that helps children sleep and feed more comfortably
- Suitable from 3 months of age — covering a broad paediatric age range including infants
- OTC — no prescription required for standard use within the recommended age range
- Trusted global brand with a well-established paediatric safety profile
- Convenient 100 mL bottle — provides multiple doses for a standard treatment course
What It Is & How It Works
Active Ingredient
Each 5 mL of syrup contains:
| Active Ingredient | Strength per 5 mL | Role |
|---|---|---|
| Pholcodine | 1 mg | Centrally acting antitussive — suppresses the cough reflex to relieve dry and tickly coughs |
How It Works
Pholcodine — Centrally Acting Antitussive
Pholcodine is an opioid-related cough suppressant (antitussive) that acts centrally on the cough centre in the medulla oblongata of the brainstem. It suppresses the cough reflex by:
- Binding to opioid receptors in the brainstem cough centre, reducing the excitability of the cough reflex arc
- Raising the threshold at which cough stimuli trigger the cough reflex — reducing both the frequency and intensity of dry, non-productive coughing episodes
- Unlike codeine, pholcodine has minimal analgesic activity and a significantly lower risk of dependence at therapeutic antitussive doses
- At the low doses used in Tixylix — 1 mg per 5 mL — pholcodine provides gentle cough suppression appropriate for young children without significant sedation or respiratory depression at recommended doses
Why Cough Suppression Is Appropriate in Young Children
A dry, tickly cough in a young child is typically non-productive — it does not bring up mucus or phlegm and serves no useful physiological purpose in clearing the airway. Instead, it irritates the throat, disrupts sleep, causes feeding difficulties, and distresses both the child and parents. In this context, gentle cough suppression with pholcodine is clinically appropriate — it provides symptomatic comfort while the underlying cold or upper respiratory tract infection resolves naturally.
Pholcodine is distinct from expectorant-based cough medicines (such as guaifenesin), which are more appropriate for chesty, productive coughs. Tixylix is specifically indicated for dry and tickly coughs only.
Classification
This product is classified as an Over-the-Counter (OTC) medicine in Kenya. It can be purchased without a prescription for standard use in children aged 3 months to 5 years. Consult a pharmacist or doctor if you are unsure whether this product is suitable for your child.
Formulation
Oral syrup. Each bottle contains 100 mL. Each 5 mL of syrup contains pholcodine 1 mg. A calibrated oral syringe or dosing spoon should be used to measure doses accurately — do not use a household teaspoon.
Uses & Indications
Tixylix Blackcurrant Cough Syrup may be used for the symptomatic relief of:
- Dry, tickly, and irritating cough in young children
- Non-productive cough associated with common colds and minor upper respiratory tract infections
- Cough that disrupts sleep or feeding in infants and young children
- Throat irritation-driven cough associated with post-nasal drip from colds
IMPORTANT: Tixylix is indicated ONLY for dry, non-productive coughs. It is NOT appropriate for chesty, productive coughs where mucus needs to be cleared — an expectorant or mucolytic would be more appropriate in that scenario. Do not use Tixylix in children under 3 months of age. If your child’s cough is accompanied by high fever, difficulty breathing, wheezing, rapid breathing, persistent vomiting, or the cough has been present for more than 5 days without improvement, seek medical attention promptly.
Dosage & Administration
NOTE: Use only as directed on the label or by a pharmacist. Do not exceed the recommended dose or duration of use. Always use the calibrated measuring device provided.
| Age Group | Dose | Frequency | Maximum Daily Dose |
|---|---|---|---|
| 3 months – under 1 year | As directed | As directed | As directed |
| 1 year – under 5 years | As directed | As directed | As directed |
| Children under 3 months | As directed | — | — |
| Children 5 years and above | As directed | — | — |
Administration Instructions
- Shake the bottle gently before each use
- Measure the dose carefully using the calibrated oral syringe or dosing spoon provided — do not use a household teaspoon as this results in inaccurate dosing in small children
- May be given directly into the child’s mouth or mixed with a small amount of water or fruit juice if preferred
- Space doses evenly throughout the day — allow at least 4 hours between doses
- Do not give more than 4 doses in any 24-hour period
- Do not use for more than 5 consecutive days without consulting a healthcare provider
- If the child’s cough does not improve within 5 days or worsens at any point, stop use and consult a doctor or pharmacist promptly
- Keep the bottle tightly closed after each use
Possible Side Effects
Tixylix Blackcurrant Cough Syrup is generally very well tolerated in young children at recommended doses. However, some children may experience the following:
Common
- Mild drowsiness — pholcodine has mild central sedative properties at antitussive doses; this is usually minimal but may occasionally be noticeable in some children
- Mild nausea or stomach discomfort — uncommon at paediatric doses; usually transient
Less Common
- Constipation — a recognised class effect of opioid-related compounds, including pholcodine, particularly with prolonged use
- Skin rash or itching — mild and usually transient
WARNING: Rare but serious — seek immediate medical attention if your child experiences: respiratory depression or difficulty breathing (rare at recommended doses but a known class risk of opioid-related compounds — do not exceed the stated dose), severe allergic reactions (rash, swelling of the face, lips, tongue, or throat, difficulty breathing or anaphylaxis), or excessive sedation or unusual difficulty waking the child. In case of accidental overdose, seek emergency medical attention immediately.
This is not a complete list of side effects. Consult a pharmacist or doctor for full information.
Warnings & Precautions
CONTRAINDICATION: Do NOT use Tixylix Blackcurrant Cough Syrup in children under 3 months of age. Do NOT use in children with known hypersensitivity to pholcodine or any excipient in this formulation.
Do Not Use If Your Child:
- Is under 3 months of age — immature respiratory control and hepatic metabolism in neonates and very young infants make opioid-related compounds unsafe below this age
- Has a known hypersensitivity to pholcodine or any other ingredient in this product
- Has a productive or chesty cough — pholcodine suppresses the cough reflex and should not be used when coughing is serving a useful function in clearing mucus from the airways
- Has respiratory depression, acute or severe asthma, or chronic obstructive airway disease — opioid-related antitussives may worsen respiratory function in these conditions
- Has liver disease — pholcodine is hepatically metabolised; consult a doctor before use in children with liver conditions
Use With Caution In Children Who Have:
- Asthma — while Tixylix may be used with caution in mild, stable asthma for dry cough relief, any sign of bronchospasm or worsening respiratory symptoms warrants immediate medical attention
- A history of constipation or bowel problems — pholcodine may worsen constipation
- Any chronic respiratory condition — consult a doctor before use
Do Not Combine With:
- Other cough and cold medicines containing antitussives — risk of duplicate ingredients and pholcodine overdose
- Sedative medicines, antihistamines with sedating properties (promethazine, chlorphenamine), or any CNS depressant — additive sedation in young children can be dangerous
- MAOIs — serious and potentially life-threatening interactions with opioid-related compounds; do not use within 14 days of MAOI therapy
CLINICAL NOTE (Kenya-specific): Cough and upper respiratory tract infections are among the most common reasons for paediatric pharmacy consultations in Kenya. Tixylix is appropriate for dry, non-productive coughs in young children — however, Kenyan parents and caregivers should be counselled to differentiate between a dry tickly cough and the productive coughs or respiratory symptoms associated with pneumonia, bronchiolitis, or tuberculosis — all of which carry significant prevalence in Kenyan children and require urgent medical assessment rather than symptomatic cough suppression. Any cough in a child under 2 years of age that is accompanied by rapid breathing, chest indrawing, grunting, poor feeding, high fever, or general deterioration must be treated as a potential lower respiratory tract infection or pneumonia and referred immediately for medical evaluation — these are medical emergencies in the Kenyan context where pneumonia remains a leading cause of childhood mortality. Additionally, parents should be reminded that cough suppressants are for symptomatic comfort only and do not treat the underlying cause of the cough.
Keep out of reach of children. In case of accidental overdose, seek emergency medical attention immediately.
Storage Instructions
- Store below 25°C in a cool, dry place
- Protect from direct sunlight and excessive heat
- Keep away from moisture and humidity
- Keep the bottle tightly closed after each use
- Do not refrigerate unless specifically directed on the label
- Store out of reach and sight of children — this product is for use in children but must be stored safely away from unsupervised access
- Do not use after the expiry date printed on the bottle or carton
- Do not transfer the syrup to another container
- Dispose of unused or expired syrup safely at your local registered pharmacy
Mandatory Disclaimer
Always read the label and use as directed. Do not exceed the stated dose for your child’s age group. If your child’s cough persists for more than 5 days, worsens, or is accompanied by high fever, difficulty breathing, wheezing, rapid breathing, or any signs of serious illness, stop use and consult a healthcare professional immediately. This product is for symptomatic relief of dry, non-productive cough only and does not treat the underlying cause of the cough. This product information is provided for general guidance only and does not replace professional medical or pharmaceutical advice.
Reviews
There are no reviews yet.